on 8 Nov 2017
Last Applicant/ Owned by
Aptorum Group Limited
Guangdong Investment Tower, 17th Floor, 148 Connaught Road
Central, ,
Serial Number
UK00003269175 filed on 8th Nov 2017
Registration Number
UK00003269175 registered on
2th Mar 2018
Correspondent Information
Dehns
St. Bride's House, 10 Salisbury Square
LONDON,
EC4Y 8JD
Pharmaceutical preparations for the diagnosis, prevention and treatment of neurological diseases and disorders; pharmaceutical preparations for the diagnosis, prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the diagnosis, prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the diagnosis, prevention and treatment of cognitive deficiencies and neurodegenerative diseases and for the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities.
Medical apparatus for the treatment of neurodegenerative diseases; medical instruments and articles, namely, analytical laboratory apparatus for analysis of neurodegenerative diseases; analysis and diagnostic apparatus for medical purposes, namely, neurology and neurobiology; medical diagnostic apparatus for the detection of neurodegenerative diseases and conditions; surgical, medical apparatus and instruments for the prevention, treatment and repair of neurodegenerative diseases and disorders; testing apparatus used for the treatment of cognitive deficiencies, neurodegenerative diseases and for the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities.
Pre-clinical and clinical services for formulation research in the field of neurodegenerative diseases; conducting clinical trials for diagnostic tests and for pharmaceutical preparations in the field of neurodegenerative diseases; scientific and toxicology research services in the field of neuroscience and neurodegenerative diseases; biopharmaceutical research for development of targeted therapies for use in the treatment of neurodegenerative diseases and disorders; providing medical testing services for research purposes and medical and scientific research information in the fields of degenerative and neurodegenerative diseases.
Consulting for pharmacology and toxicology in the field of neurodegenerative diseases and disorders; providing targeted, individualized treatment regimens, therapies or combination therapy for patients suffering from neurodegenerative diseases and disorders; medical testing for diagnostic or treatment purposes in the field of neurodegenerative diseases and disorders.
UK00003269175
Word
Individual